Serum concentration of asprosin in new-onset type 2 diabetes
Abstract Background Asprosin, a newly identified adipokine, is pathologically increased in individuals with insulin resistance. However, the available evidence on the association of asprosin and type 2 diabetes mellitus (T2DM) status is still scarce. Therefore, this study aimed to determine the rela...
Збережено в:
| Автори: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2020-07-01
|
| Серія: | Diabetology & Metabolic Syndrome |
| Предмети: | |
| Онлайн доступ: | http://link.springer.com/article/10.1186/s13098-020-00564-w |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|